Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-07-30
Item 5.07
Equitable Holdings shareholders voted at a special meeting on July 30, 2026, approving the proposed merger with Corebridge Financial by 97.24% of votes cast (85.84% of outstanding shares) and providing advisory approval of executive compensation in connection with the merger.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 85%
filed 2026-07-30
The 6-K furnishes a press release dated July 30, 2026 titled "British American Tobacco p.l.c. (the "Company") - Share Buyback Programme." Share buyback programmes are capital returns to shareholders and fall within the dividend_distribution category, which encompasses share-repurchase programs. This is material to investors as it signals capital allocation policy and affects share count and earnings per share.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-30
Item 2.02
Ameren issued a press release on July 30, 2026, announcing second quarter 2026 earnings results with diluted EPS of $1.13 versus $1.01 in the prior year, net income of $314 million versus $275 million, and reaffirmed full-year 2026 guidance of $5.25–$5.45 per share.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-30
Item 2.02
Columbus McKinnon issued a press release and earnings presentation on July 30, 2026 announcing Q1 FY27 financial results (ended June 30, 2026), disclosing record net sales of $531.5 million (125% Y/Y growth), net loss of $88.7 million, adjusted net income of $30.5 million, orders of $568.1 million, and increased full-year FY27 guidance.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-30
Item 8.01
The Board of Directors declared a quarterly dividend of $0.133 per share, payable on August 21, 2026, to stockholders of record on August 11, 2026. This is a routine but material capital distribution to shareholders. The dividend amount has been adjusted for the company's 3-for-1 stock split earlier in the month, as disclosed in the news release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-30
Item 2.02
Amazon disclosed its second quarter 2026 financial results via press release on July 30, 2026, reporting net sales of $200.6 billion (up 20% YoY), operating income of $27.5 billion (up 43% YoY), and net income of $62.6 billion ($5.75 per diluted share), with segment performance and forward guidance for Q3 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-30
Item 5.02
The Board appointed Colleen Martin-Garcia as the Company's principal accounting officer on July 29, 2026. While the disclosure also mentions Kevin Kraus's cessation of this role, the principal action disclosed is Ms. Martin-Garcia's appointment to a key officer position, supported by her compensation package (base salary $360,000, 50% target bonus, and 600,000 RSUs vesting over three years). This is a material executive appointment affecting the registrant's financial reporting structure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-30
Item 2.02
This is a quarterly earnings release for Q2 2026 disclosing net income of $3.8 billion (up 61% year-over-year), net revenues of $6.0 billion, and comprehensive income of $3.8 billion. The filing explicitly states "On July 30, 2026, Freddie Mac announced its results of operations for the quarter ended June 30, 2026" with a press release furnished as Exhibit 99.1, along with earnings presentation and financial supplement exhibits. This is a standard Item 2.02 earnings disclosure with detailed financial statements and business metrics.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-30
Item 1.01
Group 1 Automotive entered into a definitive Purchase and Sale Agreement on July 30, 2026, to acquire substantially all assets of Hennessy Automobile Companies' 10 dealerships and one collision center in Atlanta for approximately $1.3 billion plus inventory, with a $1.25 billion bridge financing commitment from JPMorgan, expected to close by year-end 2026 and generate approximately $1.7 billion in annual revenues.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-30
Item 2.02
Group 1 Automotive issued a press release on July 30, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing diluted EPS of $8.62 from continuing operations, total revenues of $5.4 billion, and net income of $103.0 million.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-30
Item 2.02
This Item 2.02 disclosure reports Mettler-Toledo's financial results for the three and six months ended June 30, 2026, with a press release attached as Exhibit 99.1. The filing presents GAAP and non-GAAP results including net sales, earnings per share (reported EPS of $11.55 vs. prior-year $9.76 for Q2; $19.87 vs. $17.56 for six months), and forward guidance for Q3 and full-year 2026. This is a standard quarterly earnings release disclosure material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-30
Item 2.02
Jones Lang LaSalle issued a news release on July 30, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing record diluted EPS of $4.59 (up 100% in local currency), revenue of $6.9 billion (up 11%), and adjusted EBITDA of $386.3 million (up 33% in local currency). The full text is attached as Exhibit 99.1 and incorporated by reference in Item 2.02, which is the standard Item for earnings releases. This is a material disclosure affecting investor assessment of the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-30
Item 2.02
YUM disclosed quarterly financial results for Q2 2026 ended June 30, 2026 via press release attached as Exhibit 99.1. The filing reports GAAP EPS of $3.08, system sales growth of 5% excluding FX, unit growth of 5%, and divisional performance metrics across KFC, Taco Bell, Pizza Hut, and Habit Burger & Grill. This is a standard earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-30
Item 2.02
Columbia Sportswear issued a press release on July 30, 2026 reporting second quarter and first half 2026 financial results, including net sales of $614.4 million, operating income of $30.9 million, and diluted EPS of $0.52, along with an updated full-year 2026 financial outlook.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-30
Item 7.01
Columbia Sportswear's Board of Directors declared a quarterly cash dividend of $0.30 per share payable on September 3, 2026 to shareholders of record on August 20, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-30
Item 2.02
This is a clear earnings release for Q2 2026 filed under Item 2.02. The press release reports quarterly financial results including EPS of $1.38 (vs. $1.16 YoY), net income of $104.3 million, record assets under management of $911.6 billion, and a declared dividend of $0.38 per share. The disclosure is material as it provides comprehensive quarterly financial performance and operational metrics that would affect investor assessment of the registrant.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-30
Item 2.02
IDACORP issued a press release on July 30, 2026 reporting second quarter 2026 financial results with net income of $102.6 million ($1.79 per diluted share) and increased its full-year 2026 earnings guidance to $6.30–$6.45 per diluted share.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-30
Item 2.02
This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure announces quarterly financial results including net loss of $81.2 million, EPS of $(0.48), Distributable EPS of $0.31, and dividend of $0.47 per share. The press release and detailed presentation (Exhibits 99.1 and 99.2) are furnished as exhibits, which is the standard format for earnings disclosures under Item 2.02.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-30
EX-99.1
This is a press release announcing Gildan's Q2 2026 financial results, including net sales of $1.58 billion (up 72.3% YoY), adjusted operating margin of 22.3%, and adjusted diluted EPS of $1.28 (up 32% YoY). The document explicitly states "Gildan Reports Strong Second Quarter Results" and provides detailed operating results, cash flows, and updated full-year 2026 guidance. While the release also announces the sale of HanesBrands Australia, the primary disclosure is the quarterly earnings announcement with comprehensive financial metrics and forward guidance.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-07-30
Item 8.01
The disclosure announces a significant customer order for RAD's autonomous security products—12 RIO Mini units and 12 ROSA units with SARA licenses—described as "RAD's largest single order to date for a data center construction application." This is a material operational/commercial milestone representing a major contract win, but it does not fit the specific categories of earnings release, M&A activity, debt issuance, or other defined event types. The order demonstrates business traction and revenue opportunity, making it material to investors assessing the company's operational performance and market adoption of its products.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-07-30
EX-99.1
This is a news release announcing First Majestic Silver Corp.'s Q2 2026 financial results, including revenue of $415.5 million (up 57% YoY), net earnings of $109.4 million, and free cash flow of $194.6 million. The release also announces a quarterly dividend of $0.0152 per share. The disclosure of quarterly financial results in a press release format is a classic earnings_release event, material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-30
Item 5.02
The disclosure centers on amendments to Mr. Mazanderani's employment agreements—extension of his U.S. employment agreement through June 30, 2029, and entry into a new South African employment agreement with specified base salaries ($600,000 USD and ZAR 5,000,000 respectively) and travel allowances. These are compensatory arrangements for a named executive officer that materially affect his terms of service and compensation structure.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-30
EX-99.1
Integra Resources filed a Feasibility Study Technical Report and updated Life of Mine Plan for the Florida Canyon Mine, disclosing a 74% increase in Proven and Probable Mineral Reserves to 1.19 million ounces of gold, an 8-year operating mine life, 17% increase in average annual gold production to approximately 82,000 ounces, and an after-tax NPV of $601 million with approximately $0.8 billion of after-tax free cash flow.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-30
Item 5.02
Anne Sweeney resigned from Netflix's Board of Directors effective July 26, 2026. The disclosure centers on a director's departure, not an appointment or compensation arrangement. Board departures are material to investors as they affect governance and oversight structure, and the filing explicitly confirms the resignation was not due to disagreement, which is a standard materiality qualifier.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-30
Item 2.02
LKQ Corporation issued a press release on July 30, 2026 disclosing second quarter 2026 financial results, including revenue of $3.4 billion, net income of $134 million, and diluted EPS of $0.52, along with an updated 2026 full-year outlook. This is a standard quarterly earnings release filed under Item 2.02 (Results of Operations and Financial Condition), with the press release furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-30
Item 2.02
PTC Therapeutics announced Q2 2026 financial results on July 30, 2026, disclosing total revenue of $361 million (including $239 million in product revenue), net income of $83.5 million, and raising full-year 2026 guidance to $1.18–$1.28 billion in total revenue.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-30
Item 5.02
Hege Sollie-Zetlmayer was appointed to PTC Therapeutics' Board of Directors effective July 28, 2026, filling a board vacancy. The appointment includes compensatory arrangements consisting of a base retainer of $50,000 and equity grants of stock options and RSUs.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-30
Item 2.02
CNX Resources Corporation disclosed its second quarter 2026 financial and operational results, including consolidated statements of income, balance sheets, and cash flows, along with production volumes, hedging data, and guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-30
The filing discloses Red River Bancshares' unaudited financial results for Q2 2026 via a press release dated July 30, 2026, reporting net income of $11.8 million ($1.78 EPS), net interest margin expansion to 3.61%, and operational highlights including loan and deposit activity. This is a standard quarterly earnings release under Item 2.02, material to investors assessing the company's financial performance and condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-30
Item 2.02
SPS Commerce issued a press release on July 30, 2026 disclosing Q2 2026 financial results, including revenue of $197.8 million (6% growth), net income of $6.9 million, and Adjusted EBITDA of $66.6 million (19% increase). The filing explicitly states this is Item 2.02 disclosure of "results of operations and financial condition for our three and six months ended June 30, 2026" with the press release attached as Exhibit 99.1, which is the standard format for earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-30
Item 2.02
DexCom issued a press release on July 30, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing revenue of $1.308 billion (13% YoY growth), GAAP operating income of $318.3 million (24.3% margin), and GAAP net income of $249.1 million ($0.64 per diluted share). The filing also includes updated 2026 annual guidance raising revenue midpoint to $5.18-$5.25 billion and increasing margin guidance. This is a standard quarterly earnings release with material financial results and forward guidance material to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-30
Item 2.02
Safehold Inc. disclosed Q2 2026 quarterly financial results, reporting revenue of $114.6 million, net income of $30.2 million, and EPS of $0.42, along with operational highlights including $150 million in new ground lease originations and a $348 million Brookfield joint venture.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-07-30
Item 8.01
Safehold Inc. disclosed an estimate of unrealized capital appreciation (UCA) of $9,770 million in its owned residual portfolio as of June 30, 2026, along with detailed methodology and valuation processes. This is a material financial disclosure regarding the company's investment portfolio valuation and residual property rights, but it does not fit neatly into specific categories like earnings release, impairment, or debt issuance. The disclosure is clearly financial in nature and material to investors assessing the company's asset values and investment quality, warranting classification as financial_other.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-30
Item 7.01
Sky Quarry disclosed completion of an at-the-market (ATM) equity offering program under which it issued approximately 4.4 million shares of common stock and raised approximately $13.5 million in net proceeds between April and June 2026. The disclosure details the sales agreement with Cantor Fitzgerald and the subsequent amended agreement with Muriel Siebert & Co., and specifies the number of shares sold and proceeds generated under each arrangement. This is a material dilutive issuance of equity securities that would affect a reasonable investor's assessment of ownership dilution and the company's capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-07-30
Item 1.01
NanoViricides completed a registered direct offering on July 27, 2026, selling 2,416,339 shares of common stock at $1.53 per share, pre-funded warrants, and common warrants to purchase 2,516,339 additional shares for approximately $3.8 million in gross proceeds. The offering was announced on July 24, 2026, pursuant to an effective Form S-3 shelf registration statement and includes a 60-day lock-up on further issuances.
View raw filing on EDGAR →
6-K
Periodic Interim
confidence 95%
filed 2026-07-30
This is a half-year (H1) interim financial report for the period ended 30 June 2026, containing consolidated financial statements, segment data, and comprehensive XBRL tagging. The document presents H1 2026 revenue (€4.7 billion), Adjusted EBIT (€716 million), Adjusted EBITDA (€880 million), and other financial metrics compared to H1 2025, along with forward guidance. This is the periodic interim financial report itself, not a discrete earnings announcement or press release, and should be deferred for separate processing as a periodic filing.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 95%
filed 2026-07-30
The filing discloses preliminary court approval of a settlement of consolidated stockholder derivative litigation (In re Latch Inc. Derivative Litigation, Case No. 1:23-cv-01273-JGK) alleging breaches of fiduciary duties and false statements regarding financial metrics. The settlement includes a $450,000 fee and expense payment to plaintiffs' counsel and comprehensive corporate governance reforms to be implemented for 3.5 years. This is a material litigation settlement that would affect a reasonable investor's assessment of the company's governance and legal exposure.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-30
The filing discloses a comprehensive renewal of BBVA's leadership team involving multiple executive appointments and departures across key functions (CFO, Global Head of Legal, Global Head of Compliance & Internal Control, Country Managers, and others). While individual appointments might be classified as exec_appointment or exec_departure, the substance here is a coordinated organizational restructuring affecting the entire C-suite and senior management. This is a material governance event that would affect a reasonable investor's assessment of the bank's leadership and strategic direction, particularly given the stated context of AI-driven transformation.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-30
Item 2.02
XPO issued a press release on July 30, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing diluted EPS of $1.36 (vs. $0.89 prior year), adjusted diluted EPS of $1.70 (vs. $1.05 prior year), revenue of $2.36 billion (vs. $2.08 billion), and adjusted EBITDA of $434 million (vs. $340 million). This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, materially affecting investor assessment of the company's financial performance and operational trends.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-30
Item 2.02
RPC, Inc. issued a press release on July 30, 2026, announcing unaudited financial results for the second quarter ended June 30, 2026, including revenues of $460.9 million, net income of $12.1 million, and diluted EPS of $0.05. The filing also discloses a regular quarterly cash dividend of $0.04 per share. This is a standard quarterly earnings release disclosure under Item 2.02, with the full press release attached as Exhibit 99.1.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-30
EX-99.1
The exhibit discloses a drone strike on the Company's Suezmax tanker Nissos Sifnos while loading at the Caspian Pipeline Consortium terminal on July 30, 2026. Although the crew remained safe and the vessel sustained only minor damages with no spill, the incident represents a material operational and security event affecting one of the Company's ten Suezmax tankers. This is an operational disruption and security incident that would affect a reasonable investor's assessment of operational risks and vessel safety, but does not fit the specific cybersecurity_incident category (which applies to information systems breaches) or other named event types.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-30
Item 5.02
Wayne D. Thorsen, Executive Vice President and Chief Operating Officer, is ceasing employment effective July 31, 2026. While the disclosure includes severance details ($1,050,000 lump sum payment and forfeiture of unvested equity), the principal disclosed action is the departure of a senior executive officer. The absence of a successor appointment and the clean separation (no disagreements noted) reinforce that this is fundamentally an exec_departure event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-30
Item 8.01
The filing discloses entry into an Agreement and Plan of Merger whereby Expand Energy Corporation will acquire Twin Eagle N.A., LLC and its subsidiaries for a base purchase price of $1.25 billion. This is a material acquisition transaction involving a merger structure with customary closing conditions and regulatory approvals required, clearly falling within the ma_activity category (Item 1.01 or 2.01 equivalent disclosure under Item 8.01).
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 92%
filed 2026-07-30
BBVA's Board of Directors resolved on 29 July 2026 to execute a share buyback program for up to €2,000 million (with an initial tranche of €1,000 million) to reduce share capital through cancellation of acquired shares. Share buyback programs are classified as dividend distributions / returns of capital to shareholders, as they represent a distribution of value to equity holders through capital reduction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-30
Item 2.02
This is a clear earnings release for Q2 2026 financial results. The filing discloses quarterly financial statements (revenue, R&D expenses, G&A expenses, net loss per share), cash position ($510.1 million), and cash runway projections into 2030. The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The financial results are material to investors assessing the company's operational performance and financial health.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-30
Item 7.01
Tvardi announced the selection of ulcerative colitis as the initial indication for its lead candidate TTI-109, following completion of a Phase 1 healthy volunteer study. This represents a material strategic and operational milestone in the company's clinical development pathway—the decision to advance a specific product candidate into a defined therapeutic area with planned IND clearance and Phase 2 initiation in 2027. While not a traditional M&A, earnings, or governance event, this disclosure of a major clinical development decision and the supporting Phase 1 data would affect a reasonable investor's assessment of the company's pipeline progress and near-term catalysts.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-30
Item 2.02
This is a clear earnings release disclosing Intercontinental Exchange's second quarter 2026 financial results. The Item 2.02 filing announces consolidated net revenues of $2.7 billion (+5% y/y), GAAP diluted EPS of $1.69 (+14% y/y), and adjusted diluted EPS of $1.90 (+5% y/y), with detailed segment breakdowns and forward guidance. The press release is attached as Exhibit 99.1 and contains comprehensive financial statements and non-GAAP reconciliations typical of quarterly earnings announcements.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-30
Item 2.02
Netlist issued a press release on July 30, 2026 announcing financial results for Q2 2026 ended June 27, 2026, disclosing net sales of $109.8 million (163% increase YoY), gross profit of $22.9 million (1,544% increase YoY), and net income of $1.4 million versus a prior-year loss of $6.1 million. The filing includes condensed consolidated financial statements and is a classic Item 2.02 earnings disclosure with material improvements in profitability and revenue.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-30
Item 7.01
Replimune disclosed attendance at an FDA Cellular, Tissue, and Gene Therapies Advisory Committee meeting on July 30, 2026, to discuss a BLA resubmission for RP1 (vusolimogene oderparepvec) in combination with nivolumab for advanced melanoma treatment. This is a material regulatory milestone for a clinical-stage biopharmaceutical company—the advisory committee meeting represents a critical juncture in the FDA approval process for a breakthrough-designated therapy. While not a formal approval or denial, the meeting and supporting presentation materials constitute a significant operational and regulatory event that would affect investor assessment of the company's pipeline progress and near-term catalysts.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-30
EX-99.1
This press release announces Instinct Bio's strategic decision to launch a subscription-model beauty clinic business under its Japanese brand "GENRÊVER CLINIC" in Indonesia, with an initial investment of approximately US$1 million across five clinics. The disclosure describes a new business line and market entry strategy positioned as a gateway to the company's regenerative-medicine focus. While this is a material operational and strategic initiative that would affect a reasonable investor's assessment of the company's business direction and capital deployment, it does not fit neatly into the specific event categories (it is neither M&A, a discrete executive change, nor a financial obligation); accordingly, it is classified as an operational/strategic business event under `operational_other`.
View raw filing on EDGAR →